USANA Health Sciences Inc (USNA) is a publicly traded Consumer Defensive sector company. As of October 23, 2026, USNA trades at $13.71 with a market cap of $268.28M and a P/E ratio of 6.55. USNA moved -3.86% today. Year to date, USNA is -23.62%; over the trailing twelve months it is -30.56%. Its 52-week range spans $12.57 to $38.32. Rallies surfaces USNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
USANA Health Sciences enters first amendment to credit agreement on Sept. 30, 2026: USANA Health Sciences amended its credit agreement on Sept. 30, 2026. The agreement provides a $75 million revolving credit facility, which may increase to $200 million, and sets minimum EBITDA requirements beginning in the fourth quarter of 2026.
| Metric | Value |
|---|---|
| Price | $13.71 |
| Market Cap | $268.28M |
| P/E Ratio | 6.55 |
| EPS | $2.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $38.32 |
| 52-Week Low | $12.57 |
| Volume | 136.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $854.50M |
| Net Income | $42.06M |
| Gross Margin | 81.13% |
USNA analyst coverage data. Average price target: $0.00.